WHAT THE EVIDENCE SAYS
Researchers tested a proposed log-scaled cumulative mixture-risk index against seasonal upstream/downstream measurements of ten pharmaceuticals near Latvian wastewater treatment plants. A minority of compounds contributed disproportionately to the screening signal.
WHY IT MATTERS / OUR READ
Site comparisons may require mixture-sensitive triage before expensive compound-specific toxicity work.
CAVEATS / UNCERTAINTY
This is a screening index, not direct measurement of additive or synergistic organism-level effects; field-wide ecological validation remains necessary.
SOURCE
Frontiers in Water — pharmaceutical-mixture screening (accepted 9 Nov 2026)
View original evidence ↗
